PDUFA dates February 2020: FDA calendar and catalysts.
0 PDUFA dates fell in February 2020. The FDA calendar also recorded 8 other catalysts that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.
PDUFA dates in February 2020
No PDUFA dates are disclosed for this period as of November 16, 2026.
Download: CSV · JSON · iCal (next 30 days, CC BY 4.0) · Calendar API · All months
February 2020: other FDA decisions and filings
| Date | Drug | Company | Event | Indication | Status | Source |
|---|---|---|---|---|---|---|
| February 4, 2020 | Vemlidy (tenofovir alafenamide fumarate) | GILD | Label expansion | — | Approved | openFDA Drugs@FDA |
| February 5, 2020 | Tecfidera (dimethyl fumarate) | BIIB | Label expansion | — | Approved | openFDA Drugs@FDA |
| February 14, 2020 | Pataday Twice Daily Relief (olopatadine hydrochloride) | ALC | Label expansion | — | Approved | openFDA Drugs@FDA |
| February 14, 2020 | Voltaren Arthritis Pain (diclofenac sodium) | HLN | Label expansion | — | Approved | openFDA Drugs@FDA |
| February 21, 2020 | Trulicity (dulaglutide) | LLY | Label expansion | — | Approved | openFDA Drugs@FDA |
| February 25, 2020 | Nerlynx (neratinib maleate) | PBYI | Label expansion | — | Approved | openFDA Drugs@FDA |
| February 27, 2020 | Nurtec Odt (rimegepant sulfate) | PFE | FDA approval | — | Approved | openFDA Drugs@FDA |
| February 28, 2020 | Advil Dual Action With Acetaminophen (acetaminophen; ibuprofen) | HLN | FDA approval | — | Approved | openFDA Drugs@FDA |
February 2020: dated readouts
No events in this view.
Questions
What PDUFA dates are in February 2020?
0 PDUFA dates fell in February 2020. The FDA calendar also recorded 8 other catalysts that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.
Can these dates change?
Yes. The FDA can extend a review by three months after a major amendment, and it sometimes acts before the goal date. Each row links the filing the date came from.
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.